Pacific Health Ventures

Pacific Health Ventures is an early-stage venture capital firm based in Menlo Park, California, specializing in healthcare technology investments. The firm primarily targets B2B SaaS platforms that aim to enhance clinical outcomes, streamline workflows, and generate new revenue streams for healthcare providers, ultimately improving the lives of patients and clinicians.

The firm's investment strategy involves actively engaging with portfolio companies, facilitating strategic partnerships with industry leaders to accelerate product-market fit and secure commercial contracts. This approach ensures that startups gain rapid traction while established companies access innovative solutions tailored to their needs.

Since its inception, Pacific Health Ventures has made several investments, including a notable Series A funding round for Relief Cardiovascular in January 2025, amounting to $12 million. The firm's portfolio also includes Winterlight Labs, a company specializing in AI-powered speech analysis for neurodegenerative diseases, and Limbix, which was acquired by Big Health in July 2023. These investments underscore Pacific Health Ventures' commitment to advancing healthcare through technological innovation.